Literature DB >> 13694224

Newer concepts in the management of tetanus.

T C COCK.   

Abstract

The problem of tetanus in California is reemphasized. The addition of new drugs holds promise that the mortality and morbidity in pediatric tetanus will be reduced. Illustrative cases are presented to emphasize this changing concept. Diagnosis and treatment are outlined. Meprobamate is incorporated in the three-phase treatment plan discussed.Further evaluation of this drug is essential with emphasis on establishment of pediatric dosage schedules and to further confirm reliability.

Entities:  

Keywords:  TETANUS/therapy

Mesh：

Substances：

Year:  1961        PMID： 13694224      PMCID： PMC1574456     

Source DB:  PubMed          Journal:  Calif Med        ISSN： 0008-1264


  12 in total

1.  Control of tetanus spasms by administration of meprobamate.

Authors:  M A PERLSTEIN
Journal:  J Am Med Assoc       Date:  1959-08-15

2.  Treatment of tetanus with acetylprmazine.

Authors:  R WRIGHT
Journal:  Trans R Soc Trop Med Hyg       Date:  1960-05       Impact factor: 2.184

3.  Management of tetanus with oral chlorpromazine.

Authors:  W B WRIGHT
Journal:  J R Nav Med Serv       Date:  1959

4.  Total paralysis regime in severe tetanus.

Authors:  S M ALHADY; D P BOWLER; H A REID; L T SCOTT
Journal:  Br Med J       Date:  1960-02-20

5.  Treatment of tetanus with chlorpromazine; two case-reports.

Authors:  W HAMILTON
Journal:  Br J Clin Pract       Date:  1959-11

6.  Generalized tetanus: analysis of 202 cases.

Authors:  M R GARCIA-PALMIERI; R RAMIREZ
Journal:  Ann Intern Med       Date:  1957-10       Impact factor: 25.391

7.  Tetanus: prophylaxis and treatment of the disease.

Authors:  D E ROSS; J J KRAUT
Journal:  Calif Med       Date:  1959-05

8.  Tetanus in California; epidemiology and a review of 232 cases.

Authors:  P K CONDIT
Journal:  Calif Med       Date:  1959-05

9.  Plasmanate: a new plasma substitute for pediatric therapy.

Authors:  T C COCK; C M BINGER; J L DENNIS
Journal:  Calif Med       Date:  1958-10

10.  The pharmacological properties of 2-methyl-2-n-propyl-1,3-propanediol dicarbamate (miltown), a new interneuronal blocking agent.

Authors:  F M BERGER
Journal:  J Pharmacol Exp Ther       Date:  1954-12       Impact factor: 4.030
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.